Browse > Article
http://dx.doi.org/10.3904/kjim.2016.358

Body fluid status assessment by bio-impedance analysis in patients presenting to the emergency department with dyspnea  

Park, Chan Soon (Department of Internal Medicine, Seoul National University Hospital)
Lee, Sang-Eun (Department of Internal Medicine, Seoul National University Hospital)
Cho, Hyun-Jai (Department of Internal Medicine, Seoul National University Hospital)
Kim, Yong-Jin (Department of Internal Medicine, Seoul National University Hospital)
Kang, Hyun-Jae (Department of Internal Medicine, Seoul National University Hospital)
Oh, Byung-Hee (Department of Internal Medicine, Seoul National University Hospital)
Lee, Hae-Young (Department of Internal Medicine, Seoul National University Hospital)
Publication Information
The Korean journal of internal medicine / v.33, no.5, 2018 , pp. 911-921 More about this Journal
Abstract
Background/Aims: Fluid retention occurs in patients with heart failure, accounting for dyspnea. We investigated the diagnostic implication of body fluid status, assessed by bio-impedance analysis (BIA), in acute heart failure (AHF) among patients who presented with dyspnea. Methods: A total of 100 patients who presented with dyspnea and suspected with AHF were analyzed in this study. We enrolled 50 AHF and 50 non-AHF patients discriminated through echocardiographic analysis and Framingham criteria and were matched by age and sex. Body composition was analyzed using a multifrequency BIA. Results: AHF patients demonstrated higher extracellular water (ECW)/total body water (TBW) compared with non-AHF patients ($0.412{\pm}0.017$ vs. $0.388{\pm}0.023$, p < 0.001). A significant difference of ECW/TBW between AHF patients and non-AHF patients was noted when the upper extremities, trunk, and lower extremities were analyzed (all p < 0.001, respectively). ECW/TBW was not different between patients with reduced ejection fraction (EF) and preserved EF along body compartments. The best cut-off value to predict AHF was > 0.412 at lower extremities with sensitivity and specificity of 0.780 and 0.960. The ECW/TBW of the lower extremities ($ECW/TBW_L$) was correlated with log B-type natriuretic peptide (BNP) levels (r = 0.603, p < 0.001) and also improved the net reclassification improvement and integrated discriminated improvement when added to log BNP level. Multivariate analysis revealed that $ECW/TBW_L$ > 0.412 had an independent association with AHF patients (p = 0.011). Conclusions: The $ECW/TBW_L$ was higher in patients with dyspnea caused by AHF than their counterparts and demonstrated an independent diagnostic implication. It may be a promising marker to diagnose AHF at bedside.
Keywords
Heart failure; Electric impedance; Dyspnea; Natriuretic peptide, brain;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chung ES, O'Brien TM, Menon S, Bartone C, Mazur W, Kereiakes DJ. A pilot study of target weight guided treatment in acute heart failure using ultrafiltration or usual care: effect on sodium removal. Korean Circ J 2014;44:156-161.   DOI
2 Yoo BS, Park JJ, Choi DJ, et al. Prognostic value of hyponatremia in heart failure patients: an analysis of the clinical characteristics and outcomes in the relation with serum sodium level in Asian Patients Hospitalized for Heart Failure (COAST) study. Korean J Intern Med 2015; 30:460-470.   DOI
3 Stevenson LW. Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Circulation 2006;113:1020-1027.   DOI
4 Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167.   DOI
5 Furstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients. Am J Kidney Dis 2011;57:123-129.   DOI
6 Kim M, Shinkai S, Murayama H, Mori S. Comparison of segmental multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body composition in a community-dwelling older population. Geriatr Gerontol Int 2015;15:1013-1022.   DOI
7 Okamoto M, Fukui M, Kurusu A, et al. Usefulness of a body composition analyzer, InBody 2.0, in chronic hemodialysis patients. Kaohsiung J Med Sci 2006;22:207-210.   DOI
8 Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377:658-666.   DOI
9 Booth J, Pinney J, Davenport A. The effect of vascular access modality on changes in fluid content in the arms as determined by multifrequency bioimpedance. Nephrol Dial Transplant 2011;26:227-231.   DOI
10 Bogonez-Franco P, Nescolarde L, Bragos R, Rosell-Ferrer J, Yandiola I. Measurement errors in multifrequency bioelectrical impedance analyzers with and without impedance electrode mismatch. Physiol Meas 2009;30:573-587.   DOI
11 Taylor AE. Capillary fluid filtration. Starling forces and lymph flow. Circ Res 1981;49:557-575.   DOI
12 Jacob M, Chappell D. Reappraising Starling: the physiology of the microcirculation. Curr Opin Crit Care 2013;19:282-289.   DOI
13 Martin-Du Pan RC, Benoit R, Girardier L. The role of body position and gravity in the symptoms and treatment of various medical diseases. Swiss Med Wkly 2004;134:543-551.
14 Man IO, Glover K, Nixon P, Poyton R, Terre R, Morrissey MC. Effect of body position on foot and ankle volume in healthy subjects. Clin Physiol Funct Imaging 2004;24:323-326.   DOI
15 Felker GM, Teerlink JR. Diagnosis and management of acute heart failure. In: Mann D, Zipes D, Libby P, Bonow R, eds. Braunwald's Heart Disease. 10th ed. Vol. 1. Philadelphia (PA): Elsevier, 2015:484-491.
16 Di Somma S, De Berardinis B, Bongiovanni C, Marino R, Ferri E, Alfei B. Use of BNP and bioimpedance to drive therapy in heart failure patients. Congest Heart Fail 2010; 16 Suppl 1:S56-S61.   DOI
17 Hara N, Iwasa M, Iwata K, et al. Value of the extracellular water ratio for assessment of cirrhotic patients with and without ascites. Hepatol Res 2009;39:1072-1079.   DOI
18 Mulasi U, Kuchnia AJ, Cole AJ, Earthman CP. Bioimpedance at the bedside: current applications, limitations, and opportunities. Nutr Clin Pract 2015;30:180-193.   DOI
19 Parrinello G, Paterna S, Di Pasquale P, et al. The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 2008;14:676-686.   DOI
20 Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88:107-115.   DOI
21 Gibson AL, Holmes JC, Desautels RL, Edmonds LB, Nuudi L. Ability of new octapolar bioimpedance spectroscopy analyzers to predict 4-component-model percentage body fat in Hispanic, black, and white adults. Am J Clin Nutr 2008;87:332-338.   DOI
22 Ling CH, de Craen AJ, Slagboom PE, et al. Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr 2011;30:610-615.   DOI
23 Bedogni G, Malavolti M, Severi S, et al. Accuracy of an eight-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nutr 2002;56:1143-1148.   DOI
24 Cha K, Chertow GM, Gonzalez J, Lazarus JM, Wilmore DW. Multifrequency bioelectrical impedance estimates the distribution of body water. J Appl Physiol (1985) 1995; 79:1316-1319.   DOI
25 Chong JU, Nam S, Kim HJ, et al. Exploration of fluid dynamics in perioperative patients using bioimpedance analysis. J Gastrointest Surg 2016;20:1020-1027.   DOI
26 Fanestil DD. Compartmentation of body water. In: Narins RG, ed. Clinical Disorders of Fluid and Electrolyte Metabolism. New York: McGraw-Hill, 1994:3-20.
27 Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab 2003;17:471-503.   DOI
28 Miller WL, Borgeson DD, Grantham JA, Luchner A, Redfield MM, Burnett JC Jr. Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure. Eur J Heart Fail 2015;17:144-150.   DOI
29 Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006;47:1-8.   DOI
30 Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure: re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008;10:165-169.   DOI
31 Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891-975.   DOI
32 Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147-e239.   DOI
33 Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574-581.   DOI
34 Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005;294:1625-1633.   DOI
35 Ling HZ, Flint J, Damgaard M, et al. Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail 2015;17:35-43.   DOI
36 Solomonica A, Burger AJ, Aronson D. Hemodynamic determinants of dyspnea improvement in acute decompensated heart failure. Circ Heart Fail 2013;6:53-60.   DOI
37 Nakagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an “emergency” cardiac hormone against ventricular overload. J Clin Invest 1995;96:1280-1287.   DOI
38 Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832.   DOI
39 Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 2010;12:423-433.   DOI
40 Berger R, Moertl D, Peter S, et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol 2010;55:645-653.   DOI